Cart
sales@molnova.com
YPC-22026
CAS No. 1964457-41-7
YPC-22026( —— )
Catalog No. M34743 CAS No. 1964457-41-7
YPC-22026 has potential anticancer activity, inducing tumor regression in a mouse xenograft model while inhibiting ZNF143-regulated genes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYPC-22026
-
NoteResearch use only, not for human use.
-
Brief DescriptionYPC-22026 has potential anticancer activity, inducing tumor regression in a mouse xenograft model while inhibiting ZNF143-regulated genes.
-
DescriptionYPC-22026 has potential anticancer activity, inducing tumor regression in a mouse xenograft model while inhibiting ZNF143-regulated genes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1964457-41-7
-
Formula Weight331.25
-
Molecular FormulaC16H8F3N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(F)OC=1C=CC=CC1C2=NN=C(C#CC=3C=NC=CC3)O2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
3-O-Coumaroylquinic ...
3-p-Coumaroylquinic acid (compound 3a) is an isomer of p-coumaroylquinic acid.
-
Adrafinil
Adrafinil?is used to relieve excessive sleepiness and inattention in elderly patients.?
-
Urocortin III, human
Urocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III (human) preferentially binds and activates CRF-R2 and has a discrete central nervous system and peripheral distribution. Urocortin III (human) selectively binds to type 2 CRF receptors with Ki values of 13.5, 21.7, and >100 nM for mCRF2β, rCRF2α, and hCRF1, respectively. Urocortin III (human) mediates somatostatin-dependent negative feedback control of Insulin (human) secretion.
